Aileron Therapeutics Inc.

NASDAQ: ALRN · Real-Time Price · USD
2.11
0.18 (9.33%)
At close: Jan 10, 2025, 10:00 PM

Aileron Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 119K 169K 121K
Gross Profit
n/a -119K -169K -121K
Operating Income
-65.11M -16.28M -27.65M -26.61M
Interest Income
n/a n/a n/a n/a
Pretax Income
-62.88M -15.73M -27.33M -26.2M
Net Income
-62.88M -15.73M -27.01M -25.76M
Selling & General & Admin
13.86M 11.36M 9.68M 9.6M
Research & Development
14.25M 3.99M 17.97M 17.01M
Other Expenses
37M 928K n/a n/a
Operating Expenses
65.11M 16.28M 27.65M 26.61M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 16.28M 27.65M 26.61M
Income Tax Expense
n/a n/a -318K -441K
Shares Outstanding (Basic)
17.94M 4.6M 4.54M 4.44M
Shares Outstanding (Diluted)
17.94M 4.6M 4.54M 4.44M
EPS (Basic)
-3.51 -3.42 -5.95 -5.8
EPS (Diluted)
-3.51 -3.42 -5.95 -5.8
EBITDA
-65.11M -15.61M -27.48M -26.48M
EBIT
n/a -15.73M -27.65M -26.61M
Depreciation & Amortization
n/a 119K 169K 121K